A Phase 1 study for safety and pharmacokinetics of BIO101 (20‐hydroxyecdysone) in healthy young and older adults
Abstract Background Sarcopenia is an age‐related skeletal muscle disorder characterized by loss of muscle mass and strength leading to mobility disability. 20‐Hydroxyecdysone (20E) is a polyhydroxylated plant steroid that demonstrates pharmacological effects in many disease animal models including a...
Main Authors: | Waly Dioh, Cendrine Tourette, Susanna Del Signore, Louiza Daudigny, Philippe Dupont, Christine Balducci, Pierre J. Dilda, René Lafont, Stanislas Veillet |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-06-01
|
Series: | Journal of Cachexia, Sarcopenia and Muscle |
Subjects: | |
Online Access: | https://doi.org/10.1002/jcsm.13195 |
Similar Items
-
BIO101 stimulates myoblast differentiation and improves muscle function in adult and old mice
by: Maria Serova, et al.
Published: (2024-02-01) -
20-Hydroxyecdysone, from Plant Extracts to Clinical Use: Therapeutic Potential for the Treatment of Neuromuscular, Cardio-Metabolic and Respiratory Diseases
by: Laurence Dinan, et al.
Published: (2021-04-01) -
Screening some of plants from Silene Genus for 20-Hydroxyecdysone
by: Nazim A. Mamedov, et al.
Published: (2017-01-01) -
Identification of genes regulated by 20-Hydroxyecdysone in Macrobrachium nipponense using comparative transcriptomic analysis
by: Huwei Yuan, et al.
Published: (2024-01-01) -
20-Hydroxyecdysone and Receptor Interplay in the Regulation of Hemolymph Glucose Level in Honeybee (<i>Apis mellifera</i>) Larvae
by: Jing Yu, et al.
Published: (2023-01-01)